Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Cytometry. Part B, Clinical Cytometry|February 12, 2017
Quantitative Flow Cytometry: Concerns and Recommendations in Clinic and ResearchOlga Mizrahi, Eliran Ish Shalom, Michal Baniyash, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczemaRachid Marhaba, Mario Vitacolonna, Dagmar Hildebrand, et al.Immunity|March 13, 2013
Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammationMoshe Sade-Feldman, Julia Kanterman, Eliran Ish-Shalom, et al.Diabetes Care|November 5, 2014
CD247, a novel T cell-derived diagnostic and prognostic biomarker for detecting disease progression and severity in patients with type 2 diabetesRoy Eldor, Yair Klieger, Moshe Sade-Feldman, et al.Molecular and Cellular Neurosciences|August 12, 2008
Neural precursor cells inhibit multiple inflammatory signalsNina Fainstein, Ilan Vaknin, Ofira Einstein, et al.Blood|November 10, 2007
A common pathway mediated through Toll-like receptors leads to T- and natural killer-cell immunosuppressionIlan Vaknin, Liora Blinder, Lynn Wang, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 27, 2015
Impaired SNX9 Expression in Immune Cells during Chronic Inflammation: Prognostic and Diagnostic ImplicationsEliran Ish-Shalom, Yaron Meirow, Moshe Sade-Feldman, et al.Cancer Research|September 12, 2014
Adverse immunoregulatory effects of 5FU and CPT11 chemotherapy on myeloid-derived suppressor cells and colorectal cancer outcomesJulia Kanterman, Moshe Sade-Feldman, Moshe Biton, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organsAnalía V Ezernitchi, Ilan Vaknin, Leonor Cohen-Daniel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2016
Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with IpilimumabMoshe Sade-Feldman, Julia Kanterman, Yair Klieger, et al.Pageof 4